课题基金 / 基金详情

HVTN 042 AVENTIS PATEUR- LIPO-5 AND ALVAC-HIV VACCINES IN HEALTHY, HIV-1 UNIN

HVTN 042 AVENTIS PATEUR- LIPO-5 AND ALVAC-HIV VACCINES IN HEALTHY, HIV-1 UNIN
HVTN 042 AVENTIS PATEUR-LIPO-5 和 ALVAC-HIV 疫苗用于健康 HIV-1 UNIN
批准号:
7731392
负责人:
PETER Edwin WRIGHT
金额:
$0.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-09-16

项目摘要

项目成果

PETER Edwin WRIGHT的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Specific Aim: To characterize the safety and tolerability of LIPO-5 (total dose of 2500 mcg) when given alone for HIV prevention.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural characterization of large eukaryotic proteins containing both folded and disordered domains
  • 批准号:
    10552345
  • 项目类别:
  • 资助金额:
    $45.25万
  • 财政年份:
    2023
  • 负责人:
    PETER Edwin WRIGHT
  • 依托单位:
Molecular mechanisms of transthyretin amyloidosis
  • 批准号:
    10115719
  • 项目类别:
  • 资助金额:
    $45.64万
  • 财政年份:
    2020
  • 负责人:
    PETER Edwin WRIGHT
  • 依托单位:
Molecular mechanisms of transthyretin amyloidosis
  • 批准号:
    10599188
  • 项目类别:
  • 资助金额:
    $46.54万
  • 财政年份:
    2020
  • 负责人:
    PETER Edwin WRIGHT
  • 依托单位:
Molecular mechanisms of transthyretin amyloidosis
  • 批准号:
    10372930
  • 项目类别:
  • 资助金额:
    $45.64万
  • 财政年份:
    2020
  • 负责人:
    PETER Edwin WRIGHT
  • 依托单位: